XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash Flows from Operating Activities          
Net earnings including noncontrolling interest $ 424.1 $ 130.7 $ 1,093.8 $ 36.3  
Adjustments to reconcile net earnings including noncontrolling interests to net cash provided by operating activities:          
Depreciation, depletion and amortization 277.0 237.9 781.7 743.4  
Deferred and other income taxes     55.7 36.2  
Equity in net (earnings) of nonconsolidated companies, net of dividends     (1.8) (49.2)  
Accretion expense for asset retirement obligations     97.5 80.9 $ 111.2
Share-based compensation expense     24.2 26.7  
Unrealized (gain) loss on derivatives     (85.1) 22.6  
Foreign Currency Transaction Loss, before Tax       117.5  
Foreign Currency Transaction Gain, before Tax     285.9    
Impairment of Long-Lived Assets to be Disposed of     73.0 0.0  
Amortization of Debt Discount (Premium)     33.6 25.1  
Other     100.8 50.3  
Changes in assets and liabilities, excluding effects of acquisition:          
Receivables, net     71.9 195.4  
Inventories     (578.9) (517.3)  
Other current and noncurrent assets     27.6 (179.7)  
Accounts payable and accrued liabilities     (169.1) 257.8  
Other noncurrent liabilities     49.6 233.9  
Net cash provided by operating activities     880.9 1,079.9  
Cash Flows from Investing Activities          
Capital expenditures     1,009.8 957.7  
Purchases of available-for-sale securities - restricted     (598.2) (1,162.0)  
Proceeds from sale of available-for-sale securities - restricted     577.9 1,119.1  
Other     7.9 16.1  
Net cash used in investing activities     (1,022.2) (984.5)  
Cash Flows from Financing Activities          
Repayments of Other Short-term Debt     (11,400.6) (12,421.3)  
Proceeds from Other Short-term Debt     11,606.0 12,572.8  
Repayments of inventory financing arrangement     (1,404.6) (1,405.1)  
Proceeds From Inventory Financing Arrangements     1,505.8 1,605.1  
Payments of structured accounts payable arrangements     (699.4) (522.3)  
Proceeds from structured accounts payable arrangements     683.5 510.2  
Proceeds from Issuance of Long-Term Debt     4.7 0.0  
Collections from Factoring Receivables     217.2 330.1  
Payments of Factoring Receivables     (217.2) (328.6)  
Payments of long-term debt     (54.5) (55.2)  
Payments for Repurchase of Common Stock     0.0 210.4  
Cash dividends paid     (210.5) (204.2)  
Payments of Ordinary Dividends, Noncontrolling Interest     (13.1) (17.6)  
Proceeds from (Payment for) Other Financing Activity     (26.7) (22.1)  
Net cash used in financing activities     (9.4) (168.6)  
Net change in cash, cash equivalents and restricted cash     (127.7) (28.7)  
Cash, cash equivalents and restricted cash-beginning of period     305.0 360.8 360.8
Cash, cash equivalents and restricted cash-end of period 177.3 332.1 177.3 332.1 305.0
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation     23.0 44.5  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]          
Cash and cash equivalents 153.3 301.6 153.3 301.6 272.8
Restricted cash in other current assets 8.0 15.1 8.0 15.1  
Restricted cash in other assets 16.0 15.4 16.0 15.4  
Cash, cash equivalents and restricted cash-end of period $ 177.3 $ 332.1 177.3 332.1 $ 305.0
Supplemental Disclosure of Cash Flow Information:          
Interest (net of amount capitalized)     113.7 114.0  
Capitalized interest costs     24.1 26.1  
Income taxes (net of refunds)     239.1 284.1  
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee     $ (407.7) $ 0.0